Ten-Year Results From a Phase II Study on Image Guided, Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in High-Risk Prostate Cancer
Fulltekst
RELATERTE DOKUMENTER
Adding abiraterone for men with high-risk prostate cancer (PCa) starting long-term androgen deprivation therapy (ADT): Survival results from STAMPEDE (NCT00268476).. Tidsskr
Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy... Conformal arc radiotherapy for prostate
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo- controlled,
Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy... Conformal arc radiotherapy for prostate
(2011) A randomized, double-blind phase III study of icotinib versus gefitinib in patients with advanced non-small cell lung cancer (NSCLC) previously treated with
Reduction in median waiting times for radiotherapy among colorectal, lung and prostate cancer patients 11.. ranged from
The survival benefit of dose-escalation with High-Dose-Rate brachytherapy (HDR-BT) combined with External Beam Radiotherapy (EBRT) for the treatment of high-risk prostate cancer
Adding abiraterone for men with high-risk prostate cancer (PCa) starting long-term androgen deprivation therapy (ADT): Survival results from STAMPEDE (NCT00268476).. Tidsskr